156 related articles for article (PubMed ID: 17364691)
1. Tumor markers in biological fluids associated with pregnancy.
Sarandakou A; Protonotariou E; Rizos D
Crit Rev Clin Lab Sci; 2007; 44(2):151-78. PubMed ID: 17364691
[TBL] [Abstract][Full Text] [Related]
2. Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy.
Sarandakou A; Kontoravdis A; Kontogeorgi Z; Rizos D; Phocas I
Eur J Obstet Gynecol Reprod Biol; 1992 May; 44(3):215-20. PubMed ID: 1607061
[TBL] [Abstract][Full Text] [Related]
3. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
[TBL] [Abstract][Full Text] [Related]
4. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
Lellé RJ; Henkel E; Leinemann D; Goeschen K
Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
[TBL] [Abstract][Full Text] [Related]
5. Measurement of Tennessee antigen, carcinoembryonic antigen, tissue polypeptide antigen and alpha-feto-protein in body fluids associated with pregnancy.
Oehr P; Bellmann O; Hamann D
Clin Biochem; 1982 Feb; 15(1):13-6. PubMed ID: 6175441
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
7. The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEA.
Tayyar M; Tutus A
Int J Fertil Womens Med; 1999; 44(5):256-9. PubMed ID: 10569455
[TBL] [Abstract][Full Text] [Related]
8. Potential function of amniotic fluid in fetal development---novel insights by comparing the composition of human amniotic fluid with umbilical cord and maternal serum at mid and late gestation.
Tong XL; Wang L; Gao TB; Qin YG; Qi YQ; Xu YP
J Chin Med Assoc; 2009 Jul; 72(7):368-73. PubMed ID: 19581143
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum and umbilical cord tumor marker levels at term pregnancy.
Kiran G; Kiran H; Guler FI; Ekerbicer HC; Kilinc M
Acta Obstet Gynecol Scand; 2005 Jan; 84(1):85-9. PubMed ID: 15603573
[TBL] [Abstract][Full Text] [Related]
10. Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Kruse R; Geilenkeuser WJ; Röhle G
Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):139-46. PubMed ID: 7683915
[TBL] [Abstract][Full Text] [Related]
11. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
12. Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery.
Itahashi K; Inaba N; Fukazawa I; Takamizawa H
Arch Gynecol Obstet; 1988; 243(4):191-7. PubMed ID: 3223775
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of circulating tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
[TBL] [Abstract][Full Text] [Related]
14. Rat alpha-fetoprotein: isolation, radioimmunoassay and fetal-maternal distribution during pregnancy.
Lai PC; Forrester PI; Hancock RL; Hay DM; Lorscheider FL
J Reprod Fertil; 1976 Sep; 48(1):1-8. PubMed ID: 61274
[TBL] [Abstract][Full Text] [Related]
15. Acquired renal cystic disease and tumor markers in chronic hemodialysis patients.
Polenakovic M; Sikole A; Dzikova S; Polenakovic B; Gelev S
Int J Artif Organs; 1997 Feb; 20(2):96-100. PubMed ID: 9093887
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen immunoreactivity in amniotic fluid.
Yu H; Diamandis EP
Clin Chem; 1995 Feb; 41(2):204-10. PubMed ID: 7533063
[TBL] [Abstract][Full Text] [Related]
17. Mucin-like carcinoma-associated antigen (MCA) during normal pregnancy.
Sarandakou A; Rizos D; Botsis D; Kassanos D; Thomopoulos P; Protonotariou E; Phocas I
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):51-4. PubMed ID: 11311760
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotrophin and alpha-fetoprotein levels in matched samples of amniotic fluid, extraembryonic coelomic fluid, and maternal serum in the first trimester of pregnancy.
Wathen NC; Cass PL; Kitau MJ; Chard T
Prenat Diagn; 1991 Mar; 11(3):145-51. PubMed ID: 1710066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
